Rhabdomyolysis in heart transplant patients on HMG-CoA reductase inhibitors and cyclosporine

Saved in:
Bibliographic Details
Published in:Transplantation proceedings 1999-09, Vol.31 (6), p.2522-2523
Main Authors: Rodrı́guez, J.A, Crespo-Leiro, M.G, Paniagua, M.J, Cuenca, J.J, Hermida, L.F, Juffé, A, Castro-Beiras, A
Format: Article
Language:English
Subjects:
Adult
Aged
Biological and medical sciences
Cholesterol - blood
Cyclosporine - adverse effects
Cyclosporine - therapeutic use
Female
Heart Transplantation - immunology
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Hypercholesterolemia - drug therapy
Immunomodulators
Immunosuppressive Agents - adverse effects
Immunosuppressive Agents - therapeutic use
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Postoperative Complications
Retrospective Studies
Rhabdomyolysis - chemically induced
Rhabdomyolysis - epidemiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0041-1345
1873-2623
DOI:10.1016/S0041-1345(99)00445-5